137 related articles for article (PubMed ID: 36240450)
1. The role of ADC value and Ki-67 index in predicting the response to neoadjuvant chemotherapy in advanced stages of olfactory neuroblastoma.
Wang Y; Zhang S; Yu W; Wang Y; Yan F; Yang B
Br J Radiol; 2022 Dec; 95(1140):20220367. PubMed ID: 36240450
[TBL] [Abstract][Full Text] [Related]
2. [Neoadjuvant chemotherapy in the treatment of locally advanced olfactory neuroblastoma in 25 cases].
Sun Y; Zhang SR; Wang MJ; Huang Q; Cui SJ; Yang BT; Qiu E; Li C; Zhou B
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2023 May; 58(5):425-430. PubMed ID: 37100753
[No Abstract] [Full Text] [Related]
3. Assessment of diffusion-weighted MRI in predicting response to neoadjuvant chemotherapy in breast cancer patients.
Hottat NA; Badr DA; Lecomte S; Besse-Hammer T; Jani JC; Cannie MM
Sci Rep; 2023 Jan; 13(1):614. PubMed ID: 36635514
[TBL] [Abstract][Full Text] [Related]
4. Diffusion-weighted MRI in pretreatment prediction of response to neoadjuvant chemotherapy in patients with breast cancer.
Richard R; Thomassin I; Chapellier M; Scemama A; de Cremoux P; Varna M; Giacchetti S; Espié M; de Kerviler E; de Bazelaire C
Eur Radiol; 2013 Sep; 23(9):2420-31. PubMed ID: 23652844
[TBL] [Abstract][Full Text] [Related]
5. Assessing the Early Response of Advanced Cervical Cancer to Neoadjuvant Chemotherapy Using Intravoxel Incoherent Motion Diffusion-weighted Magnetic Resonance Imaging: A Pilot Study.
Wang YC; Hu DY; Hu XM; Shen YQ; Meng XY; Tang H; Li Z
Chin Med J (Engl); 2016 Mar; 129(6):665-71. PubMed ID: 26960369
[TBL] [Abstract][Full Text] [Related]
6. Outcomes and Quality-of-Life Measures after Endoscopic Endonasal Resection of Kadish Stage C Olfactory Neuroblastomas.
Sun Y; Huang Q; Cui S; Wang M; Zhang N; Zhang S; Yang B; Qiu E; Huang Z; Zhou B
World Neurosurg; 2021 Jul; 151():e58-e67. PubMed ID: 33798777
[TBL] [Abstract][Full Text] [Related]
7. Neoadjuvant chemotherapy induces an elevation of tumour apparent diffusion coefficient values in patients with ovarian cancer.
Reijonen M; Holopainen E; Arponen O; Könönen M; Vanninen R; Anttila M; Sallinen H; Rinta-Kiikka I; Lindgren A
BMC Cancer; 2023 Apr; 23(1):299. PubMed ID: 37005578
[TBL] [Abstract][Full Text] [Related]
8. The prognostic value of S-100 protein and Ki-67 index in olfactory neuroblastoma.
Wang J; Wang W; Wang L; Tang T; Hu C; Song X
Jpn J Clin Oncol; 2022 Sep; 52(9):1008-1013. PubMed ID: 35818349
[TBL] [Abstract][Full Text] [Related]
9. Comparative Analysis of Amide Proton Transfer MRI and Diffusion-Weighted Imaging in Assessing p53 and Ki-67 Expression of Rectal Adenocarcinoma.
Li L; Chen W; Yan Z; Feng J; Hu S; Liu B; Liu X
J Magn Reson Imaging; 2020 Nov; 52(5):1487-1496. PubMed ID: 32524685
[TBL] [Abstract][Full Text] [Related]
10. Diffusion-weighted magnetic resonance imaging for pretreatment prediction and monitoring of treatment response of patients with locally advanced breast cancer undergoing neoadjuvant chemotherapy.
Nilsen L; Fangberget A; Geier O; Olsen DR; Seierstad T
Acta Oncol; 2010 Apr; 49(3):354-60. PubMed ID: 20397769
[TBL] [Abstract][Full Text] [Related]
11. Correlation Between Apparent Diffusion Coefficient and the Ki-67 Proliferation Index in Grading Pediatric Glioma.
Yao R; Cheng A; Zhang Z; Jin B; Yu H
J Comput Assist Tomogr; 2023 Mar-Apr 01; 47(2):322-328. PubMed ID: 36957971
[TBL] [Abstract][Full Text] [Related]
12. Whole-body diffusion-weighted MRI for evaluation of response in multiple myeloma patients following bortezomib-based therapy: A large single-center cohort study.
Zhang Y; Xiong X; Fu Z; Dai H; Yao F; Liu D; Deng S; Hu C
Eur J Radiol; 2019 Nov; 120():108695. PubMed ID: 31589995
[TBL] [Abstract][Full Text] [Related]
13. Real world data on long term outcome of neoadjuvant chemotherapy in locally advanced esthesioneuroblastoma and sinonasal tumor with neuroendocrine differentiation - Results from a single centre study.
Saha S; Patil VM; Noronha V; Menon N; Kumar Singh A; Patlekar G; Yadav N; Pai PS; Chaukar DA; Chaturvedi P; Ghosh Laskar S; Prabhash K
Oral Oncol; 2023 Sep; 144():106486. PubMed ID: 37413771
[TBL] [Abstract][Full Text] [Related]
14. Longitudinal study of the assessment by MRI and diffusion-weighted imaging of tumor response in patients with locally advanced breast cancer undergoing neoadjuvant chemotherapy.
Sharma U; Danishad KK; Seenu V; Jagannathan NR
NMR Biomed; 2009 Jan; 22(1):104-13. PubMed ID: 18384182
[TBL] [Abstract][Full Text] [Related]
15. Simultaneous changes of magnetic resonance diffusion-weighted imaging and pathological microstructure in locally advanced cervical cancer caused by neoadjuvant chemotherapy.
Fu C; Feng X; Bian D; Zhao Y; Fang X; Du W; Wang L; Wang X
J Magn Reson Imaging; 2015 Aug; 42(2):427-35. PubMed ID: 25328994
[TBL] [Abstract][Full Text] [Related]
16. Quantitative intravoxel incoherent motion parameters derived from whole-tumor volume for assessing pathological complete response to neoadjuvant chemotherapy in locally advanced rectal cancer.
Xu Q; Xu Y; Sun H; Chan Q; Shi K; Song A; Wang W
J Magn Reson Imaging; 2018 Jul; 48(1):248-258. PubMed ID: 29281151
[TBL] [Abstract][Full Text] [Related]
17. Multicenter Survival Analysis and Application of an Olfactory Neuroblastoma Staging Modification Incorporating Hyams Grade.
Choby G; Geltzeiler M; Almeida JP; Champagne PO; Chan E; Ciporen J; Chaskes MB; Fernandez-Miranda J; Gardner P; Hwang P; Ji KSY; Kalyvas A; Kong KA; McMillan R; Nayak J; O'Byrne J; Patel C; Patel Z; Peris Celda M; Pinheiro-Neto C; Sanusi O; Snyderman C; Thorp BD; Van Gompel JJ; Young SC; Zenonos G; Zwagerman NT; Wang EW
JAMA Otolaryngol Head Neck Surg; 2023 Sep; 149(9):837-844. PubMed ID: 37535372
[TBL] [Abstract][Full Text] [Related]
18. Importance of neoadjuvant chemotherapy in olfactory neuroblastoma treatment: Series report and literature review.
Bartel R; Gonzalez-Compta X; Cisa E; Cruellas F; Torres A; Rovira A; Manos M
Acta Otorrinolaringol Esp (Engl Ed); 2018; 69(4):208-213. PubMed ID: 29061289
[TBL] [Abstract][Full Text] [Related]
19. Prediction of Poor Responders to Neoadjuvant Chemotherapy in Patients with Osteosarcoma: Additive Value of Diffusion-Weighted MRI including Volumetric Analysis to Standard MRI at 3T.
Lee SK; Jee WH; Jung CK; Im SA; Chung NG; Chung YG
PLoS One; 2020; 15(3):e0229983. PubMed ID: 32155203
[TBL] [Abstract][Full Text] [Related]
20. The value of diffusion-weighted magnetic resonance imaging in assessing the response of locally advanced cervical cancer to neoadjuvant chemotherapy.
Fu C; Bian D; Liu F; Feng X; Du W; Wang X
Int J Gynecol Cancer; 2012 Jul; 22(6):1037-43. PubMed ID: 22683941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
